Literature DB >> 23079930

Surgical management of the lateral neck compartment for metastatic thyroid cancer.

Henning Dralle1, Andreas Machens.   

Abstract

PURPOSE OF REVIEW: The lateral neck compartment is the second most frequent target region for metastatic papillary thyroid cancer (PTC) and medullary thyroid cancer (MTC). Lateral lymph node metastases are associated with locoregional recurrence and, when they involve either side of the neck, with mediastinal and distant metastases. RECENT
FINDINGS: For tumors originating from the upper thyroid pole, the first nodal basin is not invariably the central compartment (as for primaries arising from the inferior thyroid pole) but often the upper part of the ipsilateral lateral compartment. Lymph node dissection of the first basin may differ depending on the location of the primary tumor. Involvement of the contralateral lateral compartment is seen in PTC with extensive central compartment involvement, and in MTC with preoperative basal calcitonin levels more than 200  pg/ml (normal limit <10  pg/ml).
SUMMARY: After lateral lymph node dissection for metastatic thyroid cancer, dysfunction of lateral neck nerves is fairly common. This observation underpins the importance of striking a balance between oncological benefit and surgical risk. Lateral lymph node dissection may be warranted for an upper thyroid pole primary, for a tumor with extensive involvement of the central compartment, and for an MTC with increased basal calcitonin level of 20-200  pg/ml (ipsilateral dissection) or more than 200  pg/ml (bilateral dissection).

Entities:  

Mesh:

Year:  2013        PMID: 23079930     DOI: 10.1097/CCO.0b013e328359ff1f

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  14 in total

1.  Diagnostic, therapeutic and health-care management protocol in thyroid surgery: a position statement of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB).

Authors:  L Rosato; C De Crea; R Bellantone; M L Brandi; G De Toma; S Filetti; P Miccoli; F Pacini; M R Pelizzo; A Pontecorvi; N Avenia; L De Pasquale; M G Chiofalo; A Gurrado; N Innaro; G La Valle; C P Lombardi; P L Marini; G Mondini; B Mullineris; L Pezzullo; M Raffaelli; M Testini; M De Palma
Journal:  J Endocrinol Invest       Date:  2016-04-08       Impact factor: 4.256

2.  Long-term outcomes of ethanol injection therapy for locally recurrent papillary thyroid cancer.

Authors:  Soo Young Kim; Seok-Mo Kim; Hojin Chang; Bup-Woo Kim; Chi Young Lim; Yong Sang Lee; Hang-Seok Chang; Cheong Soo Park
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-29       Impact factor: 2.503

3.  [Total thyroidectomy with lymph node dissection of the central compartment for node-positive, capsular invasive papillary thyroid cancer: video contribution].

Authors:  H Dralle; P Nguyen Thanh
Journal:  Chirurg       Date:  2014-10       Impact factor: 0.955

4.  Is intraoperative calcitonin monitoring useful to modulate the extension of neck dissection in patients with medullary thyroid carcinoma?

Authors:  Carmela De Crea; Marco Raffaelli; Valentina Milano; Cinzia Carrozza; Cecilia Zuppi; Rocco Bellantone; Celestino P Lombardi
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

Review 5.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

6.  Long-Term Oncologic Outcomes After Curative Resection of Familial Medullary Thyroid Carcinoma.

Authors:  Philip M Spanheimer; Ian Ganly; Joanne Chou; Marinela Capanu; Ronald A Ghossein; R Michael Tuttle; Richard J Wong; Ashok R Shaha; Brian R Untch
Journal:  Ann Surg Oncol       Date:  2019-09-23       Impact factor: 5.344

7.  The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway.

Authors:  Else Marie Opsahl; Lars Andreas Akslen; Ellen Schlichting; Turid Aas; Katrin Brauckhoff; Anne Irene Hagen; Alf Frimann Rosenlund; Eva Sigstad; Krystyna K Grøholt; Lars H Jørgensen; Trine Bjøro
Journal:  Eur Thyroid J       Date:  2019-04-29

8.  The association between tumor's location and cervical lymph nodes metastasis in papillary thyroid cancer.

Authors:  Ting-Ting Zhang; Xiu-Zhu Qi; Jian-Ping Chen; Rong-Liang Shi; Shi-Shuai Wen; Yu-Long Wang; Qing-Hai Ji; Qiang Shen; Yong-Xue Zhu; Ning Qu
Journal:  Gland Surg       Date:  2019-10

9.  Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study.

Authors:  Else Marie Opsahl; Lars Andreas Akslen; Ellen Schlichting; Turid Aas; Katrin Brauckhoff; Anne Irene Hagen; Alf Frimann Rosenlund; Eva Sigstad; Krystyna K Grøholt; Lovise Mæhle; Lars Fredrik Engebretsen; Lars H Jørgensen; Jan Erik Varhaug; Trine Bjøro
Journal:  Eur Thyroid J       Date:  2018-11-08

10.  Predictive factors of lateral lymph node metastasis in conventional papillary thyroid carcinoma.

Authors:  Muye Song; Ziyang Huang; Shujie Wang; Jianhao Huang; Hongyan Shi; Yongchen Liu; Yijie Huang; Ying Yin; Zeyu Wu
Journal:  Gland Surg       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.